BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marrugal-Lorenzo JA, Serna-Gallego A, González-González L, Buñuales M, Poutou J, Pachón J, Gonzalez-Aparicio M, Hernandez-Alcoceba R, Sánchez-Céspedes J. Inhibition of adenovirus infection by mifepristone. Antiviral Res 2018;159:77-83. [PMID: 30268911 DOI: 10.1016/j.antiviral.2018.09.011] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Labib BA, Minhas BK, Chigbu DI. Management of Adenoviral Keratoconjunctivitis: Challenges and Solutions. Clin Ophthalmol 2020;14:837-52. [PMID: 32256043 DOI: 10.2147/OPTH.S207976] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
2 Yu P, Lou D, Qi L, Chen Z. The novel antiviral properties of brassicasterol against human adenovirus. Future Virology 2021;16:591-600. [DOI: 10.2217/fvl-2021-0087] [Reference Citation Analysis]
3 Saha B, Varette O, Stanford WL, Diallo J, Parks RJ. Development of a novel screening platform for the identification of small molecule inhibitors of human adenovirus. Virology 2019;538:24-34. [DOI: 10.1016/j.virol.2019.09.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
4 Martin AJ, Jans DA. Antivirals that target the host IMPα/β1-virus interface. Biochem Soc Trans 2021;49:281-95. [PMID: 33439253 DOI: 10.1042/BST20200568] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
5 Saha B, Parks RJ. Recent Advances in Novel Antiviral Therapies against Human Adenovirus. Microorganisms 2020;8:E1284. [PMID: 32842697 DOI: 10.3390/microorganisms8091284] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Wold WSM, Tollefson AE, Ying B, Spencer JF, Toth K. Drug development against human adenoviruses and its advancement by Syrian hamster models. FEMS Microbiol Rev 2019;43:380-8. [PMID: 30916746 DOI: 10.1093/femsre/fuz008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
7 Xu J, Berastegui-Cabrera J, Chen H, Pachón J, Zhou J, Sánchez-Céspedes J. Structure-Activity Relationship Studies on Diversified Salicylamide Derivatives as Potent Inhibitors of Human Adenovirus Infection. J Med Chem 2020;63:3142-60. [PMID: 32045239 DOI: 10.1021/acs.jmedchem.9b01950] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
8 Korn D, Pervitsky V, Bobrowski T, Alves VM, Schmitt C, Bizon C, Baker N, Chirkova R, Cherkasov A, Muratov E, Tropsha A. COVID-19 Knowledge Extractor (COKE): A Curated Repository of Drug-Target Associations Extracted from the CORD-19 Corpus of Scientific Publications on COVID-19. J Chem Inf Model 2021. [PMID: 34783553 DOI: 10.1021/acs.jcim.1c01285] [Reference Citation Analysis]
9 Dailey Garnes NJM, Ragoonanan D, Aboulhosn A. Adenovirus infection and disease in recipients of hematopoietic cell transplantation. Curr Opin Infect Dis 2019;32:591-600. [PMID: 31567568 DOI: 10.1097/QCO.0000000000000605] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
10 Schein CH. Repurposing approved drugs on the pathway to novel therapies. Med Res Rev 2020;40:586-605. [PMID: 31432544 DOI: 10.1002/med.21627] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 7.3] [Reference Citation Analysis]
11 Shen Q, Wang YE, Palazzo AF. Crosstalk between nucleocytoplasmic trafficking and the innate immune response to viral infection. J Biol Chem 2021;297:100856. [PMID: 34097873 DOI: 10.1016/j.jbc.2021.100856] [Reference Citation Analysis]
12 Saha B, Parks RJ. Identification of human adenovirus replication inhibitors from a library of small molecules targeting cellular epigenetic regulators. Virology 2021;555:102-10. [PMID: 33032802 DOI: 10.1016/j.virol.2020.07.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
13 Korn D, Pervitsky V, Bobrowski T, Alves V, Schmitt C, Bizon C, Baker N, Chirkova R, Cherkasov A, Muratov E, Tropsha A. COVID-19 Knowledge Extractor (COKE): A Tool and a Web Portal to Extract Drug - Target Protein Associations from the CORD-19 Corpus of Scientific Publications on COVID-19. ChemRxiv 2020. [PMID: 33269341 DOI: 10.26434/chemrxiv.13289222] [Reference Citation Analysis]
14 Marrugal-Lorenzo JA, Serna-Gallego A, Berastegui-Cabrera J, Pachón J, Sánchez-Céspedes J. Repositioning salicylanilide anthelmintic drugs to treat adenovirus infections. Sci Rep 2019;9:17. [PMID: 30626902 DOI: 10.1038/s41598-018-37290-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
15 Tessier TM, Dodge MJ, Prusinkiewicz MA, Mymryk JS. Viral Appropriation: Laying Claim to Host Nuclear Transport Machinery. Cells 2019;8:E559. [PMID: 31181773 DOI: 10.3390/cells8060559] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
16 Dalidowska I, Gazi O, Sulejczak D, Przybylski M, Bieganowski P. Heat Shock Protein 90 Chaperones E1A Early Protein of Adenovirus 5 and Is Essential for Replication of the Virus. Int J Mol Sci 2021;22:2020. [PMID: 33670684 DOI: 10.3390/ijms22042020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]